Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1 (CAP2P1)
- Target
- CAP2P1
- Molecular classification
- Other (Pseudogene)
01
Overview
Cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1 (CAP2P1) is a human pseudogene, meaning it is a non-functional genomic segment resembling the protein-coding gene CAP2 but does not encode an active protein product. CAP2P1 is not a receptor, enzyme, or any typical target for drugs. There are no current reports of CAP2P1 being a direct therapeutic target or involved in disease mechanisms, though database associations with cardiovascular traits have been noted without demonstration of causality. If you are seeking information on the functional protein “Cyclase-associated actin cytoskeleton regulatory protein 2” (CAP2), see CAP2, which is critical for actin dynamics in muscle and neurons and involved in relevant physiological and disease processes[2][3][4].
- Other names
- CAP, adenylate cyclase-associated protein, 2 pseudogene 1adenylyl cyclase-associated protein 2 pseudogene 1CAP2P1
02
Disease associations
Other (Some database associations with “Atrial Fibrillation,” but no established mechanistic or therapeutic link[3])
Beyond the preview
Go deeper on Cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1 (CAP2P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyclase associated actin cytoskeleton regulatory protein 2 pseudogene 1 (CAP2P1).